Professor Darren Gray
Areas of expertise
- Epidemiology 111706
- Infectious Diseases 110309
- Medical Parasitology 110803
- Health Promotion 111712
- Public Health 4206
- Microbiology 3107
Research interests
Neglected Tropical Diseases
WASH
Cluster-randomised controlled trials
One Health
COVID-19
Biography
Professor Darren Gray – an infectious disease epidemiologist – is Acting Director of the Research School of Population Health; and Head of its Department of Global Health. His current research investigates the transmission and control of Tropical Infectious Diseases, some of the most prevalent and important pathogens that cause much suffering and economic loss worldwide. He aims to develop new public health interventions against these diseases that will lead to their sustainable control and eventual elimination.
Projects and Grants
Grants information is drawn from ARIES. To add or update Projects or Grants information please contact your College Research Office.
- Sewerage Surveillance for SARS-CoV-2 in the ACT (Secondary Investigator)
- Eliminating the major Helminth Neglected Tropical Diseases from the Lower Mekong Basin (Primary Investigator)
- The Australian Centre for the Control and Elimination of Neglected Tropical Diseases (Secondary Investigator)
- A Randomized Controlled Trial to Evaluate the Impact of Combining Hygiene Education with Deworming (Primary Investigator)
- Conquering schistosomiasis in China: the last mile (Secondary Investigator)
- Sustainable control and elimination of Neglected Tropical Diseases in the Asia-Pacific (Primary Investigator)
- The effectiveness, acceptability and cost effectiveness of the 'BALatrine': a culturally acceptable latrine intervention in resource limited environments. (Primary Investigator)
- A school-based health package for the prevention of soil-transmitted helminth infections in China and the Philippines (Primary Investigator)
- A cluster RCT of the impact of a community-based hygiene and sanitation programme on infection with intestinal parasites following mass albendazole chemotherapy in Timor-Leste (Secondary Investigator)